Literature DB >> 3044565

Psychopharmacologic management of patients with borderline personality disorder.

P S Links1, M Steiner.   

Abstract

This paper reviews recent literature on the psychopharmacologic management of borderline personality disorder (BPD) patients and discusses an approach to drug therapy. Five randomized controlled trials have shown positive, but non-specific effects of antipsychotic drugs on the symptoms suffered by BPD patients. There were too few data on other types of drugs to draw any conclusion. We propose that BPD patients be treated on the basis of being in a state or episode of co-existing Axis I disorder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044565     DOI: 10.1177/070674378803300508

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  2 in total

1.  The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.

Authors:  S Kutcher; G Papatheodorou; S Reiter; D Gardner
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

2.  Neurobehavioral study of borderline personality disorder.

Authors:  R van Reekum; C A Conway; D Gansler; R White; D L Bachman
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.